Authors: SANDSTROM M FREIJS A LARSSON R NYGREN P FJALLSKOG ML BERGH J KARLSSON MO

Citation: M. Sandstrom et al., LACK OF RELATIONSHIP BETWEEN SYSTEMIC EXPOSURE FOR THE COMPONENT DRUGS OF THE FLUOROURACIL, EPIRUBICIN, AND 4-HYDROXYCYCLOPHOSPHAMIDE REGIMEN IN BREAST-CANCER PATIENTS, Journal of clinical oncology, 14(5), 1996, pp. 1581-1588

Authors: NORBERG T JANSSON T SJOGREN S MARTENSSON C ANDREASSON I FJALLSKOG ML LINDMAN H NORDGREN H LINDGREN A HOLMBERG L BERGH J

Citation: T. Norberg et al., OVERVIEW ON HUMAN BREAST-CANCER WITH FOCUS ON PROGNOSTIC AND PREDICTIVE FACTORS WITH SPECIAL ATTENTION ON THE TUMOR-SUPPRESSOR GENE P53, Acta oncologica, 35(5), 1996, pp. 96-102

Authors: FJALLSKOG ML FRII L BERGH J

Citation: Ml. Fjallskog et al., PACLITAXEL-INDUCED CYTOTOXICITY - THE EFFECTS OF CREMOPHOR-EL (CASTOR-OIL) ON 2 HUMAN BREAST-CANCER CELL-LINES WITH ACQUIRED MULTIDRUG-RESISTANT PHENOTYPE AND INDUCED EXPRESSION OF THE PERMEABILITY GLYCOPROTEIN (VOL 30A, PG 687, 1994), European journal of cancer, 30A(6), 1994, pp. 896-896

Authors: FJALLSKOG ML FRII L BERGH J

Citation: Ml. Fjallskog et al., PACLITAXEL-INDUCED CYTOTOXICITY - THE EFFECTS OF CREMOPHOR-EL (CASTOR-OIL) ON 2 HUMAN BREAST-CANCER CELL-LINES WITH ACQUIRED MULTIDRUG-RESISTANT PHENOTYPE AND INDUCED EXPRESSION OF THE PERMEABILITY GLYCOPROTEIN, European journal of cancer, 30A(5), 1994, pp. 687-690

Authors: FJALLSKOG ML FRII L BERGH J

Citation: Ml. Fjallskog et al., IS CREMOPHOR EL, SOLVENT FOR PACLITAXEL, CYTOTOXIC, Lancet, 342(8875), 1993, pp. 873-873